Single-stranded DNA oligoaptamers: Molecular recognition and LPS antagonism are length- and secondary structure-dependent

Journal of Innate Immunity

Volumn 1, Issue 1, 2008, Pages 46-58

  Ding, J L ^a   Gan, S T ^a   Ho, B ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Binding kinetics; Endotoxin neutralization; Molecular recognition; Oligonucleotides; SsDNA aptamers

Indexed keywords

APTAMER; LIPID A; LIPOPOLYSACCHARIDE; SINGLE STRANDED DNA; THYMIDINE;

ARTICLE; BINDING AFFINITY; CHEMICAL STRUCTURE; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DNA ISOLATION; DNA LIBRARY; DNA SEQUENCE; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; IMMOBILIZATION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; SERODIAGNOSIS;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; DNA, SINGLE-STRANDED; HUMANS; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; MONOCYTES; NUCLEIC ACID CONFORMATION; SELEX APTAMER TECHNIQUE;

EID: 77953425115     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000145542     Document Type: Article

References (38)

1. Downey JS, Han J: Cellular activation mechanisms in septic shock. Front Biosci 1998; 3: d468-d476.
2. Tall A: Plasma lipid transfer proteins. Annu Rev Biochem 1995; 64: 235-257.
3. Brun-Buisson C, Doyon F, Carlet J, Della-monica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Regnier B: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995; 274: 968-974.
4. Lamping N, Hoess A, Yu B, Park TC, Kirschning CJ, Pfeil D, Reuter D, Wright SD, Herrmann F, Schumann RR: Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J Immunol 1996; 157: 4648-4656.
5. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ: Structure and function of lipopolysaccharide binding protein. Science 199 0; 249: 14 2 9 -14 31.
6. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249:1431-1433.
7. Rietschel ET, Brade H: Bacterial endotoxins. Sci Am 1992; 267:54-61.
8. Watson RW, Redmond HP, Bouchier-Hayes D: Role of endotoxin in mononuclear phagocyte-mediated inflammatory responses. J Leukoc Biol 1994; 56: 95-103.
9. Rietschel ET, Brade H, Holst O, Brade L, Muller-Loennies S, Mamat U, Zahringer U, Beckmann F, Seydel U, Brandenburg K, Ulmer AJ, Mattern T, Heine H, Schletter J, Loppnow H, Schonbeck U, Flad HD, Hauschildt S, Schade UF, Di Padova F, Kusu moto S, Schumann RR: Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 1996; 216:39-81.
10. Bone RC, Balk RA, Fein AM, Perl TM, Wenzel RP, Reines HD, Quenzer RW, Iberti TJ, Macintyre N, Schein RM: A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med 1995; 23:994-1006.
11. Greenman RL, Schein RM, Martin MA, Wenzel RP, MacIntyre NR, Emmanuel G, Chmel H, Kohler RB, McCarthy M, Plouffe J, et al: A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of Gram-negative sepsis. The XOMA Sepsis Study Group. JAMA 1991; 266:1097-1102.
12. Abraham E, Anzueto A, Gutierrez G, Tessler S, San Pedro G, Wunderink R, Dal Nogare A, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pennington J, Porter S: Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet 1998; 351:929-933.
13. Cohen J, Carlet J: INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med 1996; 24: 1431-1440.
14. Tuerk C, Gold L: Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249: 505-510.
15. Robertson DL, Joyce GF: Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. Nature 1990; 344: 467-468.
16. Ellington AD, Szostak JW: Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature 1992; 355:850-852.
17. Jayasena SD: Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 1999; 45:1628-1650.
18. Gebhardt K, Shokraei A, Babaie E, Lindqvist BH: RNA aptamers to S-adenosylhomocysteine: kinetic properties, divalent cation dependency, and comparison with anti-S-adenosylhomocysteine antibody. Biochemistry 2000; 39: 7255-7265.
19. Dwarakanath S, Bruno JG, Shastry A, Phillips T, John AA, Kumar A, Stephenson LD: Quantum dot-antibody and aptamer conjugates shift fluorescence upon binding bacteria. Biochem Biophys Res Commun 2004; 325:739-743.
20. Li C, Ng ML, Zhu Y, Ho B, Ding JL: Tandem repeats of Sushi3 peptide with enhanced LPS-binding and -neutralizing activities. Protein Eng 2003; 16:629-635.
21. Ding JL, Ho B: A new era in pyrogen testing. Trends Biotechnol 2001; 19:277-281.
22. Glauser MP, Zanetti G, Baumgartner JD, Cohen J: Septic shock: pathogenesis. Lancet 1991; 338: 732-736.
23. Riedemann NC, Guo RF, Ward PA: Novel strategies for the treatment of sepsis. Nat Med 2003; 9: 517-524.
24. Blank M, Weinschenk T, Priemer M, Schluesener H: Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. Selective targeting of endothelial regulatory protein pigpen. J Biol Chem 2001; 276:16464-16468.
25. Fukusaki E, Hasunuma T, Kajiyama S, Okazawa A, Itoh TJ, Kobayashi A: SELEX for tubulin affords specific T-rich DNA aptamers. Systematic evolution of ligands by exponential enrichment. Bioorg Med Chem Lett 2001; 11:2927-2930.
26. Wang C, Zhang M, Yang G, Zhang D, Ding H, Wang H, Fan M, Shen B, Shao N: Single-stranded DNA aptamers that bind differentiated but not parental cells: subtractive systematic evolution of ligands by exponential enrichment. J Biotechnol 2003; 102: 15-22.
27. Aurell CA, Wistrom AO: Critical aggregation concentrations of Gram-negative bacterial lipopolysaccharides. Biochem Biophys Res Commun 1998; 253:119-123.
28. Luderitz O, Galanos C, Lehmann V, Mayer H, Rietschel ET, Weckesser J: Chemical structure and biological activities of lipid A's from various bacterial families. Naturwis-senschaften 1978; 65: 578-585.
29. Ruckman J, Green LS, Beeson J, Waugh S, Gillette WL, Henninger DD, Claesson-Welsh L, Janjic N: 2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem 1998; 273: 20556-20567.
30. Hicke BJ, Watson SR, Koenig A, Lynott CK, Bargatze RF, Chang YF, Ringquist S, Moon-McDermott L, Jennings S, Fitzwater T, Han HL, Varki N, Albinana I, Willis MC, Varki A, Parma D: DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice. J Clin Invest 1996; 98:2688-2692.
31. Wen JD, Gray CW, Gray DM: SELEX selection of high-affinity oligonucleotides for bacteriophage Ff gene 5 protein. Biochemistry 2001; 40: 9300-9310.
32. Yang Q, Goldstein IJ, Mei HY, Engelke DR: DNA ligands that bind tightly and selectively to cellobiose. Proc Natl Acad Sci USA 1998; 95: 5462-5467.
33. Padmanabhan K, Padmanabhan KP, Ferrara JD, Sadler JE, Tulinsky A: The structure of α-thrombin inhibited by a 15-mer single-stranded DNA aptamer. J Biol Chem 1993; 268: 17651-17654.
34. Huizenga DE, Szostak JW: A DNA aptamer that binds adenosine and ATP. Biochemistry 1995; 34: 656-665.
35. Weiss S, Proske D, Neumann M, Groschup MH, Kretzschmar HA, Famulok M, Winnacker EL: RNA aptamers specifically interact with the prion protein PrP. J Virol 1997; 71: 8790-8797.
36. Schneider D, Gold L, Platt T: Selective enrichment of RNA species for tight binding to Escherichia coli rho factor. FASEB J 1993; 7: 201-207.
37. Dankesreiter S, Hoess A, Schneider-Mergener J, Wagner H, Miethke T: Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-αproduction by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock. J Immunol 2000; 164: 4804-4811.
38. Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW: The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol 1992; 148: 532-537.